help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nestel, P. J.
Right arrow Articles by West, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nestel, P. J.
Right arrow Articles by West, L.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 3 895-898
Copyright © 1999 by The Endocrine Society

Original Studies

Isoflavones from Red Clover Improve Systemic Arterial Compliance But Not Plasma Lipids in Menopausal Women1

Paul J. Nestel, Sylvia Pomeroy, Sally Kay, Paul Komesaroff, Julie Behrsing, James D. Cameron and Leanne West

Baker Medical Research Institute and Latrobe University (J.D.C.), Melbourne 8008; and Novogen Ltd. (L.W.), North Ryde 2113, Australia

Address all correspondence and requests for reprints to: Dr. P. J. Nestel, Baker Medical Research Institute, P.O. Box 6492, Melbourne 8008, Australia.

The possibility that the heightened cardiovascular risk associated with the menopause can be reduced by increasing dietary isoflavone intake was tested in 17 women by measuring arterial compliance, an index of the elasticity of large arteries such as the thoracic aorta. Compliance diminishes with age and menopause.

An initial 3- to 4-week run-in period and a 5-week placebo period were followed by two 5-week periods of active treatment with 40 mg and then 80 mg isoflavones derived from red clover containing genistein, daidzein, biochanin, and formononetin in 14 and 13 women, respectively, with 3 others serving as placebo controls throughout. Arterial compliance, measured by ultrasound as a pressure (carotid artery) and volume (outflow into aorta) relationship, was determined after each period; plasma lipids were measured twice during each period. Urinary output of isoflavones was also determined.

Arterial compliance rose by 23% relative to that during the placebo period with the 80-mg isoflavone dose and slightly less with the 40-mg dose (mean ± SEM: placebo, 19.7 ± 1.5; 40 mg, 23.7 ± 0.7; 80 mg, 24.4 ± 1.4). In the three women receiving continuous placebo, compliance was 16 ± 2.2, similar to that during the run-in period for the remaining subjects (17 ± 2.1). ANOVA showed a significant (P = < 0.001) difference between treatments; by Bonferroni multiple comparisons and by paired t test, differences were significant between placebo and 40- and 80-mg isoflavone doses (by paired t test: P = 0.039 for placebo vs. 40 mg; P = 0.018 for placebo vs. 80 mg). Plasma lipids were not significantly affected.

An important cardiovascular risk factor, arterial compliance, which diminishes with menopause, was significantly improved with red clover isoflavones. As diminished compliance leads to systolic hypertension and may increase left ventricular work, the findings indicate a potential new therapeutic approach for improved cardiovascular function after menopause.




This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
A. A Thorp, P. R. Howe, T. A Mori, A. M Coates, J. D Buckley, J. Hodgson, J. Mansour, and B. J Meyer
Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers
Am. J. Clinical Nutrition, August 1, 2008; 88(2): 298 - 304.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Gonzalez, V. Jayagopal, E. S. Kilpatrick, T. Chapman, and S. L. Atkin
Effects of Isoflavone Dietary Supplementation on Cardiovascular Risk Factors in Type 2 Diabetes
Diabetes Care, July 1, 2007; 30(7): 1871 - 1873.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
F. K. Welty, K. S. Lee, N. S. Lew, and J.-R. Zhou
Effect of Soy Nuts on Blood Pressure and Lipid Levels in Hypertensive, Prehypertensive, and Normotensive Postmenopausal Women
Arch Intern Med, May 28, 2007; 167(10): 1060 - 1067.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
L. B. Michaud, J. P. Karpinski, K. L. Jones, and J. Espirito
Dietary supplements in patients with cancer: Risks and key concepts, part 2
Am. J. Health Syst. Pharm., March 1, 2007; 64(5): 467 - 480.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. W. Erdman Jr., D. Balentine, L. Arab, G. Beecher, J. T. Dwyer, J. Folts, J. Harnly, P. Hollman, C. L. Keen, G. Mazza, et al.
Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC
J. Nutr., March 1, 2007; 137(3): 718S - 737S.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
H. J. Teede, D. Giannopoulos, F. S. Dalais, J. Hodgson, and B. P. McGrath
Randomised, Controlled, Cross-Over Trial of Soy Protein with Isoflavones on Blood Pressure and Arterial Function in Hypertensive Subjects
J. Am. Coll. Nutr., December 1, 2006; 25(6): 533 - 540.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Dewell, P. L. W. Hollenbeck, and C. B. Hollenbeck
A Critical Evaluation of the Role of Soy Protein and Isoflavone Supplementation in the Control of Plasma Cholesterol Concentrations
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 772 - 780.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
G. Douglas, J. A. Armitage, P. D. Taylor, J. R. Lawson, G. E. Mann, and L. Poston
Cardiovascular consequences of life-long exposure to dietary isoflavones in the rat
J. Physiol., March 1, 2006; 571(2): 477 - 487.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. Hallund, G. Ravn-Haren, S. Bugel, T. Tholstrup, and I. Tetens
A Lignan Complex Isolated from Flaxseed Does Not Affect Plasma Lipid Concentrations or Antioxidant Capacity in Healthy Postmenopausal Women
J. Nutr., January 1, 2006; 136(1): 112 - 116.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
Y. Ma, D. Chiriboga, B. C. Olendzki, R. Nicolosi, P. A. Merriam, and I. S. Ockene
Effect of Soy Protein Containing Isoflavones on Blood Lipids in Moderately Hypercholesterolemic Adults: A Randomized Controlled Trial
J. Am. Coll. Nutr., August 1, 2005; 24(4): 275 - 285.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
G. Williamson and C. Manach
Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 243S - 255S.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
X.-G. Zhuo, M. K. Melby, and S. Watanabe
Soy Isoflavone Intake Lowers Serum LDL Cholesterol: A Meta-Analysis of 8 Randomized Controlled Trials in Humans
J. Nutr., September 1, 2004; 134(9): 2395 - 2400.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. Kreijkamp-Kaspers, L. Kok, D. E. Grobbee, E. H. F. de Haan, A. Aleman, J. W. Lampe, and Y. T. van der Schouw
Effect of Soy Protein Containing Isoflavones on Cognitive Function, Bone Mineral Density, and Plasma Lipids in Postmenopausal Women: A Randomized Controlled Trial
JAMA, July 7, 2004; 292(1): 65 - 74.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. G. Sobey, J. M. Weiler, M. Boujaoude, and O. L. Woodman
Effect of Short-Term Phytoestrogen Treatment in Male Rats on Nitric Oxide-Mediated Responses of Carotid and Cerebral Arteries: Comparison with 17{beta}-Estradiol
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 135 - 140.
[Abstract] [Full Text] [PDF]

Home page
 Integr Cancer TherHome page
C. E. Piersen
Phytoestrogens in Botanical Dietary Supplements: Implications for Cancer
Integr Cancer Ther, June 1, 2003; 2(2): 120 - 138.
[Abstract] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
H. J. Teede, B. P. McGrath, L. DeSilva, M. Cehun, A. Fassoulakis, and P. J. Nestel
Isoflavones Reduce Arterial Stiffness: A Placebo-Controlled Study in Men and Postmenopausal Women
Arterioscler. Thromb. Vasc. Biol., June 1, 2003; 23(6): 1066 - 1071.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. S. Kurzer
Phytoestrogen Supplement Use by Women
J. Nutr., June 1, 2003; 133(6): 1983S - 1986.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
P. Nestel
Role of Soy Protein in Cholesterol-Lowering: How Good Is It?
Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1743 - 1744.
[Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. H. Lichtenstein, S. M. Jalbert, H. Adlercreutz, B. R. Goldin, H. Rasmussen, E. J. Schaefer, and L. M. Ausman
Lipoprotein Response to Diets High in Soy or Animal Protein With and Without Isoflavones in Moderately Hypercholesterolemic Subjects
Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1852 - 1858.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
D. A.J.M. Kerckhoffs, F. Brouns, G. Hornstra, and R. P. Mensink
Effects on the Human Serum Lipoprotein Profile of {beta}-Glucan, Soy Protein and Isoflavones, Plant Sterols and Stanols, Garlic and Tocotrienols
J. Nutr., September 1, 2002; 132(9): 2494 - 2505.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. S. Anthony
Phytoestrogens and Cardiovascular Disease: Where's the Meat?
Arterioscler. Thromb. Vasc. Biol., August 1, 2002; 22(8): 1245 - 1247.
[Full Text] [PDF]

Home page
 J. Nutr.Home page
N. Tsunoda, S. Pomeroy, and P. Nestel
Absorption in Humans of Isoflavones from Soy and Red Clover Is Similar
J. Nutr., August 1, 2002; 132(8): 2199 - 2201.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
Y. T. van der Schouw, A. Pijpe, C. E.I. Lebrun, M. L. Bots, P. H.M. Peeters, W. A. van Staveren, S. W.J. Lamberts, and D. E. Grobbee
Higher Usual Dietary Intake of Phytoestrogens Is Associated With Lower Aortic Stiffness in Postmenopausal Women
Arterioscler. Thromb. Vasc. Biol., August 1, 2002; 22(8): 1316 - 1322.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Dewell, C. Hollenbeck, and B. Bruce
Authors' Response: Soy Supplement--Why Is the Effect So Elusive?
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3508 - 3509.
[Full Text] [PDF]

Home page
 Obstet GynecolHome page
K. K. Han, J. M. Soares Jr, M. A. Haidar, G. R. de Lima, and E. C. Baracat
Benefits of Soy Isoflavone Therapeutic Regimen on Menopausal Symptoms
Obstet. Gynecol., March 1, 2002; 99(3): 389 - 394.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
A. J Husband and M. de Lemos
Phytoestrogens and menopause
BMJ, January 5, 2002; 324(7328): 52 - 52.
[Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Dewell, C. B. Hollenbeck, and B. Bruce
The Effects of Soy-Derived Phytoestrogens on Serum Lipids and Lipoproteins in Moderately Hypercholesterolemic Postmenopausal Women
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 118 - 121.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. E. Burdette, J. Liu, D. Lantvit, E. Lim, N. Booth, K. P. L. Bhat, S. Hedayat, R. B. Van Breemen, A. I. Constantinou, J. M. Pezzuto, et al.
Trifolium pratense (Red Clover) Exhibits Estrogenic Effects In Vivo in Ovariectomized Sprague-Dawley Rats
J. Nutr., January 1, 2002; 132(1): 27 - 30.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
P. J Nestel
How good is chocolate?
Am. J. Clinical Nutrition, November 1, 2001; 74(5): 563 - 564.
[Full Text] [PDF]

Home page
 J. Nutr.Home page
M. J. Messina and C. L. Loprinzi
Soy for Breast Cancer Survivors: A Critical Review of the Literature
J. Nutr., November 1, 2001; 131(11): 3095S - 3108.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
K. D. R. Setchell
Soy Isoflavones--Benefits and Risks from Nature's Selective Estrogen Receptor Modulators (SERMs)
J. Am. Coll. Nutr., October 1, 2001; 20(90005): 354S - 362.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
S. B. Dent, C. T. Peterson, L. D. Brace, J. H. Swain, M. B. Reddy, K. B. Hanson, J. G. Robinson, and D. L. Alekel
Soy Protein Intake by Perimenopausal Women Does Not Affect Circulating Lipids and Lipoproteins or Coagulation and Fibrinolytic Factors
J. Nutr., September 1, 2001; 131(9): 2280 - 2287.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. J. Teede, F. S. Dalais, D. Kotsopoulos, Y.-L. Liang, S. Davis, and B. P. McGrath
Dietary Soy Has Both Beneficial and Potentially Adverse Cardiovascular Effects: A Placebo-Controlled Study in Men and Postmenopausal Women
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3053 - 3060.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. E. Burow, S. M. Boue, B. M. Collins-Burow, L. I. Melnik, B. N. Duong, C. H. Carter-Wientjes, S. Li, T. E. Wiese, T. E. Cleveland, and J. A. McLachlan
Phytochemical Glyceollins, Isolated from Soy, Mediate Antihormonal Effects through Estrogen Receptor {{alpha}} and {beta}
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1750 - 1758.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
K. D. R. Setchell, N. M. Brown, P. Desai, L. Zimmer-Nechemias, B. E. Wolfe, W. T. Brashear, A. S. Kirschner, A. Cassidy, and J. E. Heubi
Bioavailability of Pure Isoflavones in Healthy Humans and Analysis of Commercial Soy Isoflavone Supplements
J. Nutr., April 1, 2001; 131(4): 1362S - 1375.
[Abstract] [Full Text]

Home page
 Am. J. Clin. Nutr.Home page
K. E Wangen, A. M Duncan, X. Xu, and M. S Kurzer
Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women
Am. J. Clinical Nutrition, February 1, 2001; 73(2): 225 - 231.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
Poster Presentation Abstracts
J. Nutr., March 1, 2000; 130(3): 680 - 680.
[Full Text]

Home page
 Endocr. Rev.Home page
J. V. Pinkerton and R. Santen
Alternatives to the Use of Estrogen in Postmenopausal Women
Endocr. Rev., June 1, 1999; 20(3): 308 - 320.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society